StockWatch
·

Amerise Biosciences Ltd Q3 FY26 Results

AMERISEQ3 FY26 Results
Filing
MetricValue ( Cr)vs Q2 FY26
Revenue0.00
Total Income0.0433.5%
Expenditure0.0467.9%
PBT0.01122.9%
Net Profit0.01122.9%
OPM
NPM21.60%84.27pp
EPS0.00100.0%
View full financials

Informational and educational content only. Not investment advice.